September was full
of events for the pharma and biotech community.
GCT President, Dr. Jeffrey Apter, participated at the annual Autumn conference organized by the International Society for CNS Clinical Trials and Methology (ISCTM).
From 21 to 25 of September professionals all over the world took part virtually in the #ISCTM2020.
The topics addressing clinical, regulatory, methodological and policy challenges in CNS clinical trials were among the many discussed.
GCT is a global CRO focused on CNS and Neurology clinical trials, and on the market since 2001.
Dr. Jeffrey Apter, GCT president is the Key Opinion Leader in psychiatry specializing in Alzheimer’s disease and Depression research. Should you have any questions or require information about clinical trials, please contact us at firstname.lastname@example.org